Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06458686
Other study ID # 1234
Secondary ID
Status Not yet recruiting
Phase Phase 1/Phase 2
First received
Last updated
Start date June 30, 2024
Est. completion date September 30, 2026

Study information

Verified date June 2024
Source German University in Cairo
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

University students are susceptible to psychological burdens such as depressive symptoms, anxiety, and stress which might have been linked to vitamin D deficiency. Low serum vitamin D level is well recognized around the world. Vitamin D has been reported to modulate several neurological pathways in the brain that control psychological function. As a result, the purpose of this study is to evaluate the effect of vitamin D supplementation on the presence of depressive symptoms, anxiety, and stress in university students. The study will include two phases. The first phase is a cross-sectional phase assessing the prevalence vitamin D deficiency in addition to psychological symptoms. The second phase is a randomized controlled clinical trial that aims to assess the effect of vitamin D supplementation on the prevalent psychological symptoms and its impact on the academic performance among university students. The study will look at the relationship between mental health and vitamin D deficiency, as well as how it will affect academic performance of university students.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 70
Est. completion date September 30, 2026
Est. primary completion date June 30, 2026
Accepts healthy volunteers No
Gender All
Age group 18 Years to 22 Years
Eligibility Inclusion Criteria: - For phase 1: sample will be selected using convenient sampling method where all students with an age range 18-22 years old fulfilling the eligibility criteria will be educated about the study protocol and will be asked to participate in the study. For phase 2: students who diagnosed with deficient vitamin D level will be asked to participate in the study. Exclusion Criteria: - Hypersensitivity to oral vitamin D supplements such as Diviton or Vidrop. - Students taking medications affecting vitamin D metabolism such as anti-seizure medications: phenytoin, phenobarbital and carbamazepine, isotretinoin, steroids: dexamethasone, antibiotics: isoniazid and rifampin and antifungals: clotrimazole. - Students taking antidepressants, drug for bipolar disorder treatment like lithium and antipsychotic agents like olanzapine. - Students with insufficient vitamin D level (20-30 ng/mL). - Students with confirmed diagnosis with psychiatric illness. - Students with a history of liver disease or dysfunction. - Students with a history of kidney disease or dysfunction.

Study Design


Intervention

Drug:
Vit D
Vitamin D is a fat soluble vitamin used for the treatment of many diseases.
Other:
Placebo
Placebo is a non drug formulation

Locations

Country Name City State
n/a

Sponsors (3)

Lead Sponsor Collaborator
German University in Cairo Prof. May Ahmed Shawki, Clinical Pharmacy Department, Ain Shams University, Egypt, Prof. Mohamed Hassan Solayman, Clinical pharmacy Department, German University in Cairo

Outcome

Type Measure Description Time frame Safety issue
Primary Evaluation of the correlation between vitamin D deficiency and presence and severity of anxiety, stress and depressive symptoms. Evaluation of the correlation between vitamin D deficiency and presence and severity of anxiety, stress and depressive symptoms. 3 months
See also
  Status Clinical Trial Phase
Completed NCT03409991 - Testing the Efficacy of Opening Doors: A Career Guidance Intervention for Individuals With Psychiatric Disabilities N/A
Not yet recruiting NCT05316948 - Mental Health and Sexuality in Adolescents and Young Adults
Completed NCT04778163 - The Use of Humor With Young Adults in Psychiatric Care N/A
Not yet recruiting NCT06304363 - Braining - Evaluation of Acute Effects of Physical Exercise N/A
Recruiting NCT04096625 - Enhancement of a Psychotherapeutic Intervention Through Transcranial Direct Current Stimulation (tDCS) N/A
Not yet recruiting NCT05930353 - Psychometric Validation of a French-language Version of the PERMA-Profiler: Tools for Assessing Multidimensional Subjective Well-being
Terminated NCT06012981 - Psychological Treatment in Psychiatric Inpatient Care N/A
Completed NCT04099173 - A Brief Mindfulness-Based Intervention for Suicidal Ideation N/A
Completed NCT01866956 - Computerized Screening for Comorbidity in Adolescents With Substance or Psychiatric Disorders
Recruiting NCT04249960 - Sustain and Reinforce the Transition From Child to Adult Mental Health Care in Switzerland : A Monocentric Nested Cohort Randomized Controlled Trial: The SORT Study. N/A
Recruiting NCT05962424 - HNC: Human Neural Circuits Electrophysiology During Cognition Phase 1
Recruiting NCT06092866 - Digital Versus Telephone Symptom Assessment and Triage in Primary Care N/A
Recruiting NCT03678194 - Treating Depression on a Day-to-day Basis: Development of a Tool for Physicians Based on a Smartphone Application N/A
Completed NCT03748355 - Using Pharmacogenetics to Identify Patients With Polypharmacy at Risk of Medication Adverse Effects N/A
Completed NCT05473962 - Mid-Term Follow-up Assessment After Exposure to Natural Disaster
Recruiting NCT05577585 - Ketamine and Stress in OCD N/A
Completed NCT05124158 - COVID-19 Severity and Psychiatric Morbidity
Recruiting NCT05560581 - Digital Self-efficacy Training to Bridge Waiting Times for Psychotherapy N/A
Completed NCT04618250 - Improving Physical Health in Patients With Psychiatric Disorders in General Practice (SOFIA) N/A
Not yet recruiting NCT06014164 - Qualitative Study About Psychedelics Using in Psychiatric Disorders